Image Processing, Modeling and Simulation Software
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), specifically the Division of Product Quality and Research (DPQR), is seeking proposals for Image Processing, Modeling and Simulation Software. This Solicitation aims to procure an advanced, cloud-based image analysis platform to assist reviewers and regulatory researchers in assessing product quality attributes. This is a Total Small Business Set-Aside. Proposals are due June 23, 2026, by 3:00 PM ET.
Scope of Work
The requirement is for a comprehensive image analysis platform (Item 001) that includes workflow management, data management, storage, and computing resource management. Key capabilities must include handling large image/quantitative data, creating complex workflows, segmenting imaging data using traditional, machine learning, and deep learning techniques, extracting quantitative information, and predictive simulation of critical quality attributes. The platform must feature a browser-based multi-user interface, be deployable on FDA HPC clusters (Linux-based, specific hardware/software requirements including Google Chrome, 8+ core CPU, 128GB+ RAM, 2TB+ Storage, GPU, Ubuntu 20.04/Redhat, Docker), comply with FDA 21 CFR Part 11, and offer a digital queue management system. Item 002 covers delivery, installation (in-person or screen sharing), user training, and on-demand customer support.
Contract & Timeline
- Contract Type: Firm Fixed Price (FFP) purchase order.
- Period of Performance: Anticipated 12-month software license from September 30, 2025, through September 29, 2026.
- Delivery: Items by September 30, 2026; licenses within 30 calendar days after award.
- Submission Deadline: June 23, 2026, by 3:00 PM ET.
- Questions Due: June 22, 2026.
- Published: June 16, 2026.
Evaluation
Award will be made to the responsible Quoter whose quotation conforms to requirements and represents the best value to the Government, defined as Lowest Price Technically Acceptable (LPTA). Quotes must meet all technical requirements, and prices will be evaluated for accuracy. The FDA intends to award without clarification or discussions.
Eligibility / Set-Aside
This procurement is a Total Small Business Set-Aside with an applicable size standard of 150 employees. Offerors must be authorized resellers or servicing agents.
Additional Notes
All electronic documents must be submitted without macros. The solicitation incorporates FAR and HHSAR provisions and clauses. The Government is not obligated to make an award or pay costs incurred by the Contractor in preparing quotes.